Privigen® use and haemolytic anaemia in adults and children and the Privigen® safety profile in children with CIDP - an observational hospital-based cohort study in the US (Privigen PASS) First published 12/03/2014 Last updated 14/03/2024 EU PAS number:EUPAS6040 Study Ongoing